Ocular Surface

Scope & Guideline

Transforming Ophthalmic Research for a Brighter Tomorrow

Introduction

Welcome to the Ocular Surface information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Ocular Surface, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1542-0124
PublisherELSEVIER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2003 to 2024
AbbreviationOCUL SURF / Ocul. Surf.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Ocular Surface' primarily focuses on advancing the understanding and management of ocular surface diseases, including innovative therapies and diagnostic methods. It serves as a platform for research that intersects clinical and experimental studies, aiming to improve patient outcomes through translational research.
  1. Ocular Surface Diseases:
    The journal encompasses a wide range of conditions affecting the ocular surface, including dry eye disease, keratitis, and conjunctivitis. Research in this area often investigates pathophysiology, epidemiology, and clinical management.
  2. Innovative Therapeutics:
    A significant focus is on the development and evaluation of novel therapeutic strategies, including gene therapy, stem cell therapy, and new pharmacological agents, designed to address ocular surface disorders.
  3. Diagnostic Advances:
    The journal highlights advancements in diagnostic techniques, such as imaging technologies (e.g., optical coherence tomography), molecular profiling, and artificial intelligence applications in diagnosing ocular diseases.
  4. Translational Research:
    Emphasis on translational research that bridges laboratory findings with clinical applications, aiming to enhance the understanding and treatment of ocular surface diseases.
  5. Multidisciplinary Approaches:
    The journal encourages interdisciplinary research involving ophthalmology, immunology, molecular biology, and bioengineering to explore complex ocular surface conditions.
Recent publications in 'Ocular Surface' indicate a shift towards trending and emerging themes, reflecting current challenges and advancements in the field. These themes are increasingly relevant as they address novel approaches and technologies in ocular surface research.
  1. Artificial Intelligence and Machine Learning:
    There is a growing interest in applying AI and machine learning techniques for diagnosing ocular surface diseases, enhancing accuracy and efficiency in clinical settings.
  2. Regenerative Medicine and Stem Cell Therapy:
    Research into regenerative approaches, particularly stem cell therapies for ocular surface restoration, is gaining momentum as a promising area of exploration for severe conditions.
  3. Molecular Mechanisms of Disease:
    A trend towards understanding the molecular underpinnings of ocular surface diseases is emerging, with studies focusing on cytokines, lipid mediators, and genetic factors influencing pathologies.
  4. Personalized Medicine:
    The shift towards personalized approaches in treatment, considering individual patient profiles and specific disease mechanisms, is becoming increasingly prominent in recent research.
  5. Impact of Digital Technology on Ocular Health:
    Research exploring the effects of digital screen use on ocular health and dry eye symptoms is on the rise, reflecting contemporary lifestyle challenges faced by patients.

Declining or Waning

While 'Ocular Surface' continues to thrive in many areas, certain themes and topics have shown signs of declining interest or publication frequency over recent years. This may reflect shifts in research focus or advancements in understanding that have led to the resolution of previously pressing questions.
  1. Traditional Pharmacological Treatments:
    Research into conventional treatments for dry eye disease, such as cyclosporine and corticosteroids, appears to be waning as novel therapeutic approaches gain traction.
  2. Epidemiological Studies:
    The frequency of purely epidemiological studies on ocular surface diseases has decreased, possibly due to an increased focus on molecular and mechanistic investigations.
  3. Basic Science of Ocular Anatomy:
    While foundational knowledge is vital, there seems to be a reduced emphasis on basic anatomical studies of the ocular surface, as more targeted and clinical research takes precedence.
  4. Historical Perspectives:
    Papers with a historical focus on ocular surface diseases and treatments are less common, indicating a shift towards contemporary issues and cutting-edge research.
  5. General Reviews without Novel Insights:
    There is a decline in general review articles that do not present new findings or insights, as the journal shifts to prioritize original research and innovative reviews.

Similar Journals

OPHTHALMOLOGY

Empowering professionals with cutting-edge insights in ophthalmology.
Publisher: ELSEVIER SCIENCE INCISSN: 0161-6420Frequency: 12 issues/year

OPHTHALMOLOGY is a leading journal in the field of ocular health, widely recognized for its contributions to advancing the understanding and treatment of ophthalmic conditions. Published by ELSEVIER SCIENCE INC in the United States, it has earned a prestigious place within the academic community, boasting a remarkable Q1 ranking in the ophthalmology category for 2023, along with an impressive Scopus rank of #2 out of 137, placing it in the 98th percentile. With a strong publication history dating back to 1958, OPHTHALMOLOGY encompasses high-quality research articles, reviews, and clinical studies that address critical issues in the field. Researchers, professionals, and students alike can access its comprehensive research through traditional subscription options, fostering an ongoing dialogue among experts. Whether you are seeking the latest treatments, understanding complex ocular diseases, or looking to advance your knowledge, OPHTHALMOLOGY remains an essential resource for cutting-edge research and insights.

JAPANESE JOURNAL OF OPHTHALMOLOGY

Advancing the Vision of Ophthalmology
Publisher: SPRINGER JAPAN KKISSN: 0021-5155Frequency: 6 issues/year

Japanese Journal of Ophthalmology, published by Springer Japan KK, is a premier peer-reviewed journal dedicated to advancing the field of ophthalmology. With an impressive impact reflected in its Q1 categories—ranking among the top journals in both Medicine (miscellaneous) and Ophthalmology, as per the 2023 metrics—it serves as an essential platform for researchers and professionals to disseminate their findings. Covering a broad spectrum of topics from clinical studies to innovative technologies in eye care, this journal not only supports the ongoing education of its readership but also fosters significant developments within the field. The journal, which has been in circulation since 1973 and is set to continue through 2024, offers access to vital research, thereby enabling practitioners and scholars to keep abreast of the latest advancements. Its distinguished Scopus ranking of #30 out of 137 in Medicine - Ophthalmology, placing it in the 78th percentile, further underscores its influence and importance in contributing to the global understanding of eye health.

International Journal of Ophthalmology

Pioneering Discoveries in Eye Care and Treatment
Publisher: IJO PRESSISSN: 2222-3959Frequency: 12 issues/year

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

Journal of the Egyptian Ophthalmological Society

Exploring new horizons in eye health and research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2090-0686Frequency: 4 issues/year

Journal of the Egyptian Ophthalmological Society is a premier academic journal dedicated to advancing the field of ophthalmology through high-quality peer-reviewed research. Published by Wolters Kluwer Medknow Publications, this journal plays a critical role in disseminating vital findings and innovations in eye care, fostering knowledge exchange among researchers, practitioners, and educators worldwide. Since its transformation to Open Access in 2014, it has significantly enhanced the accessibility of eye health information, thereby broadening its impact on the global scientific community. With an ISSN of 2090-0686 and an E-ISSN of 2314-6648, the journal aims to tackle contemporary issues in ophthalmology, including clinical practices, public health, and technological advancements in eye care. The journal's commitment to excellence ensures that it remains a vital resource for those looking to contribute meaningfully to this dynamic and crucial field.

Journal of Ophthalmic Inflammation and Infection

Bridging knowledge gaps in ophthalmology and infectious diseases.
Publisher: SPRINGERISSN: 1869-5760Frequency: 1 issue/year

The Journal of Ophthalmic Inflammation and Infection, published by SPRINGER since 2011, stands as a pivotal resource for professionals in the fields of ophthalmology and infectious diseases. With an impactful Q2 ranking in both categories as of 2023, this open access journal is dedicated to disseminating high-quality research and reviews related to ocular inflammation and its infectious causes, fostering a deeper understanding of these critical health issues. The journal is well-regarded in the academic community, currently positioned at Rank #43 in Ophthalmology, reflecting its significance and influence within the discipline. The journal is accessible globally from its base in Germany, offering valuable insights to researchers, healthcare professionals, and students alike. With a commitment to excellence in publishing through 2024 and beyond, this journal continues to contribute meaningfully to innovative studies and clinical practices in ocular health.

Asia-Pacific Journal of Ophthalmology

Leading the charge in ophthalmic advancements.
Publisher: ASIA-PACIFIC ACAD OPHTHALMOLOGY-APAOISSN: Frequency: 6 issues/year

Asia-Pacific Journal of Ophthalmology is a distinguished open access journal published by the Asia-Pacific Academy of Ophthalmology (APAO), specializing in the latest advancements and research in ophthalmology. Since its inception in 2013, this journal has established itself as a vital platform for disseminating innovative findings and clinical practices across the Asia-Pacific region and beyond. With an impressive Scopus ranking of #10 out of 137 in the field of Medicine (Ophthalmology), placing it in the 93rd percentile, it garners significant attention and respect within the academic community. Currently holding a Q1 categorization in both Medicine (miscellaneous) and Ophthalmology, the journal embraces a broad scope that encompasses clinical studies, experimental research, and reviews aimed at enhancing the understanding and management of eye health. Its open access model since 2019 ensures that all published works are freely accessible, promoting greater collaboration and knowledge sharing among researchers, clinicians, and students. Situated in the Netherlands with a prominent address in Hong Kong, the journal serves as an essential resource for anyone dedicated to the field of ophthalmology.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Exploring therapeutic frontiers for eye diseases.
Publisher: MARY ANN LIEBERT, INCISSN: 1080-7683Frequency: 10 issues/year

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, published by Mary Ann Liebert, Inc, stands at the forefront of research in the realms of ophthalmology and pharmacology. Established in 1985 and converging until 2024, this esteemed journal is dedicated to advancing the understanding of ocular pharmacology, drug therapies, and therapeutic approaches in the treatment of eye diseases. With an impressive impact factor and categorized in the Q2 quartile for both Ophthalmology and Medical Pharmacology, it showcases pivotal research in the field, reflecting its rank of #31 among 137 in Ophthalmology and #109 among 272 in Medical Pharmacology per Scopus metrics. Although it follows a subscription-based model, the journal provides critical insights and empirical studies that foster innovation and collaboration for researchers, professionals, and students alike in the pursuit of improving ocular health.

Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology

Advancing Eye Health Through Research
Publisher: GALENOS PUBL HOUSEISSN: 1300-0659Frequency: 6 issues/year

Turk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

Shaping the landscape of ophthalmology since 1966.
Publisher: CANADIAN OPHTHAL SOCISSN: 0008-4182Frequency: 6 issues/year

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

PROGRESS IN RETINAL AND EYE RESEARCH

Transforming Insights into Eye Health
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1350-9462Frequency: 6 issues/year

PROGRESS IN RETINAL AND EYE RESEARCH, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to the advancement of knowledge in the fields of ophthalmology and sensory systems. With an impressive impact factor and a Q1 category ranking in both Ophthalmology and Sensory Systems as of 2023, this journal exemplifies excellence in research dissemination. Given its stature, it ranks #1 out of 137 in Ophthalmology and #1 out of 42 in Neuroscience - Sensory Systems, placing it within the top percentile of scientific publications in these domains. The journal has been actively contributing to the field since its inception in 1994 and continues to be a vital resource for researchers, clinicians, and students seeking the latest insights and breakthroughs in the understanding of retinal diseases and eye health. While it maintains a traditional subscription model, the journal remains committed to publishing high-quality, peer-reviewed articles that drive forward the frontiers of eye research and therapeutic innovation. With its strong scientific rigor and a vast array of articles, PROGRESS IN RETINAL AND EYE RESEARCH is indispensable for anyone invested in the study of visual sciences.